Society of Hematologic Oncology's Annual Meeting

newsroom

Q&As

expert Q&A

Analyzing First-line Therapy for Multiple Myeloma: Real-World Data Differs From Trials

10/18/2022

Joshua Richter, MD, associate professor of medicine, hematology, and oncology, Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai, reviews real-world data presented at the SOHO 2022 Annual...

10/18/2022

Research Summaries

Conference Coverage

Intrathecal Methotrexate Effective In CSF Clearance, Improving Neurologic Symptoms In AML Patients With CNS Involvement

09/29/2023

Anthony Calabro, MA

Researchers retrospectively identified patients with CNS AML and evaluated several treatments and outcomes for this type of cancer at two large academic institutions.

09/29/2023

Conference Coverage

Poor Outcomes for Patients With T‑Cell Prolymphocytic Leukemia After Allogenic Transplant

09/08/2023

Anthony Calabro, MA

Researchers reported on the treatment approaches and outcomes of patients with T‑cell prolymphocytic leukemia after allogeneic transplant in a multicenter, retrospective study.

09/08/2023

Conference Coverage

Momelotinib Lowers Transfusion Requirements in Patients With Transfusion‑Dependent Myelofibrosis

09/07/2023

Anthony Calabro, MA

Researchers set out to determine how momelotinib impacts patients’ overall transfusion burden.

09/07/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4